RF9 trifluoroacetate salt
CAS: 876310-60-0
Ref. 3D-FR108335
| 1mg | 403.00 € | ||
| 2mg | 538.00 € | ||
| 5mg | 717.00 € | ||
| 10mg | 1,125.00 € | ||
| 25mg | 1,928.00 € |
Estimated delivery in United States, on Friday 31 Jan 2025
Product Information
Name:
RF9 trifluoroacetate salt
Synonyms:
- 1-Adamantanecarbonyl-Arg-Phe-NH2
- 2-Adamantanecarbonyl-Arg-Phe-Nh2 Trifluoroacetate
- <span class="text-smallcaps">L</smallcap>-Phenylalaninamide, N<sup>2</sup>-(tricyclo[3.3.1.1<sup>3,7</sup>]dec-1-ylcarbonyl)-<smallcap>L</span>-arginyl-
- N<sup>2</sup>-(Tricyclo[3.3.1.1<sup>3,7</sup>]dec-1-ylcarbonyl)-<span class="text-smallcaps">L</smallcap>-arginyl-<smallcap>L</span>-phenylalaninamide
- Rf 9
- 16: PN: WO2011144714 SEQID: 16 claimed sequence
- N2-(Tricyclo[3.3.1.13,7]dec-1-ylcarbonyl)-L-arginyl-L-phenylalaninamide
- L-Phenylalaninamide, N2-(tricyclo[3.3.1.13,7]dec-1-ylcarbonyl)-L-arginyl-
Description:
RF9 is a dipeptide that is structurally similar to the endogenous neuropeptides kisspeptin and arginine-vasopressin. RF9 binds to the GPR54 receptor, which is a G protein-coupled receptor that regulates secretion of luteinizing hormone in the anterior pituitary gland, as well as sexual desire and function. RF9 has been shown to be an antagonist of the GPR54 receptor and has been shown to inhibit the secretion of luteinizing hormone in primates.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
482.62 g/mol
Formula:
C26H38N6O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 3D-FR108335 RF9 trifluoroacetate salt
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
